TipRanks
Cellectar Biosciences (DE:NV40)
FRANKFURT:NV40
Germany Market
NV40
Cellectar Biosciences
RESEARCH TOOLSreports

Cellectar Biosciences (NV40) Stock News & Sentiment

1 Followers
Cellectar Biosciences Earnings Call Highlights Clinical Momentum
Premium
Company Announcements
Cellectar Biosciences Earnings Call Highlights Clinical Momentum
2M ago
CLRB
Cellectar: Solid Cash Runway and De-Risking Clinical Milestones Support Buy Rating; $10 Price Target Reiterated
Premium
Ratings
Cellectar: Solid Cash Runway and De-Risking Clinical Milestones Support Buy Rating; $10 Price Target Reiterated
2M ago
CLRB
Cellectar’s New Phase 3 WM Trial Puts Iopofosine I 131 on Investors’ Radar
Premium
Company Announcements
Cellectar’s New Phase 3 WM Trial Puts Iopofosine I 131 on Investors’ Radar
2M ago
CLRB
Cellectar Biosciences Inc (CLRB) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Cellectar Biosciences Inc (CLRB) Q2 Earnings Cheat Sheet
2M ago
CLRB
Cellectar Biosciences Shareholders Approve Key Governance Measures
Premium
Company Announcements
Cellectar Biosciences Shareholders Approve Key Governance Measures
3M ago
8K
CLRB
Cellectar Biosciences Bets on Iopofosine Breakthrough
Premium
Company Announcements
Cellectar Biosciences Bets on Iopofosine Breakthrough
5M ago
CLRB
Cellectar Biosciences Announces Board Changes and New Director
Premium
Company Announcements
Cellectar Biosciences Announces Board Changes and New Director
5M ago
8K
CLRB
More DE:NV40 News >

NV40 News on the Web

Cellectar: Solid Cash Runway and De-Risking Clinical Milestones Support Buy Rating; $10 Price Target Reiterated
TipRanks News
Bullish
Cellectar Biosciences Inc (CLRB) Q2 Earnings Cheat Sheet
TipRanks News
Bullish
Cellectar Biosciences publishes iopofosine I 131 dose-escalation study results
TipRanks News
Bullish
Cellectar Biosciences initiated with a Buy at Brookline
TipRanks News
Bullish
Cellectar Biosciences Shareholders Approve Key Governance Measures
TipRanks News
Neutral
Cellectar Biosciences Bets on Iopofosine Breakthrough
TipRanks News
Bullish
Cellectar Biosciences files to sell 51.21M shares of common stock for holders
TipRanks News
Neutral
Cellectar Biosciences Announces Board Changes and New Director
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0.25 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:NV40’s Media Buzz Sentiment?
Currently, no data Available
What is DE:NV40’s weekly average amount of articles?
In an average week, 0.25 articles about DE:NV40 are published.
    What is DE:NV40’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    REGNRegeneron
    QTTBQ32 Bio
    NVSNovartis
    RHHVFRoche Holding AG
    KRROKorro Bio
    Showing the stocks with the most bullish news sentiment over the past week